Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rajeev M. Shah currently holds 1,546,621 shares of Ra Pharmaceuticals, Inc. (RARX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rajeev M. Shah has been a net buyer of RARX stock. They have purchased $598.0M and sold $46.4M worth of shares.
Rajeev M. Shah's most recent insider trade was on Oct 30, 2025, when they sold 335,364 shares at $0.00 per share.
Rajeev M. Shah serves as Executive at Ra Pharmaceuticals, Inc. (RARX). They have executed 135 insider transactions totaling $644.4M over their tenure at the company.
Rajeev M. Shah holds the position of Executive at Ra Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Rajeev M. Shah has shown a buying trading pattern, with $598.0M in total purchases and $46.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Rajeev M. Shah was on Dec 9, 2022, when they purchased $50.0M worth of VOR shares. This transaction involved 11,627,907 shares at $4.30 per share.
Rajeev M. Shah currently owns 1,546,621 shares of Ra Pharmaceuticals, Inc. (RARX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rajeev M. Shah's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rajeev M. Shah has 135 Form 4 filings on record as an insider at Ra Pharmaceuticals, Inc..
Set alerts for Rajeev M. Shah and 40,000+ other insiders.